CClinicalTrials.gg
CompletedNCT03838198Updated May 28, 2021Results posted

An Adaptive Intervention for Adolescents at Risk for Suicide: A Pilot SMART

An interventional study of MI-Enhanced Safety Plan at Hospitalization (1st Component) and MI-Enhanced Text Boosters (2nd Component) in Suicide and Self Harm, sponsored by University of Michigan. Completed at 1 site in United States. Open to participants aged 13 Years to 17 Years. Per ClinicalTrials.gov, last updated 2021-05-28.

Sponsored by University of Michigan · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
82
Allocation
Randomized
Ages
13 Years to 17 Years
Sex
All
01

Study summary

To inform the development of a technology-augmented adaptive intervention for adolescents at risk for suicide, the goal of this study is to conduct a Sequential, Multiple Assignment, Randomized Trial (SMART) pilot of a Motivational Interview (MI)-enhanced safety planning intervention (MI-SafeCope). Findings from this study will provide the groundwork for the construction of a technology-augmented adaptive intervention that could lead to a reduction in suicidal behaviors and related events during the high-risk post-discharge period-an important suicide prevention target.

02

Conditions studied

  • Suicide
  • Self Harm

Browse trials for

Keywords

  • Adaptive Intervention
  • Sequential, Multiple Assignment, Randomized Trial (SMART)
  • Adolescent
  • Motivational Interviewing
  • Suicide attempt
  • Safety planning
  • mobile technology
03

In context

Suicide

701 studies on the registry are indexed under Suicide; 183 are open to participants now.

This study's enrollment of 82 is below the median of 104 across 560 interventional studies indexed under Suicide.

Browse Suicide studies →

Lead sponsor

University of Michigan is the lead sponsor of 1,475 studies on the registry; 196 are open to participants now.

Of its 162 completed or terminated interventional studies of FDA-regulated products, 128 (79%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
13 Years to 17 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Suicide attempt (previous month), and/or
  • Suicidal ideation (previous week)

Exclusion criteria

Exclusion Criteria:

  • Severe cognitive impairment or altered mental status (psychosis, manic state)
  • Transfer to medical unit or residential placement
  • No availability of a legal guardian
  • No cell phone with text messaging capability
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Sequential assignment
Masking
None (open label)
Enrollment
82 participants (actual)

Study arms

  • Other
    Safety plan + booster text messages + booster call (Group A)

    Sequencing of MI-SafeCope intervention components (Phase 1 and Phase 2) resulting in Group A: Participants will receive the in-person MI-enhanced safety plan (individual meeting with the adolescent and a family meeting) during hospitalization -- focused on developing a personalized list of coping strategies and enhancing adolescents' motivation and self-efficacy to utilize these strategies-- which will be followed by 4 weeks of daily post-discharge booster text messages and a phone booster call.

    Behavioral: MI-Enhanced Safety Plan at Hospitalization (1st Component) · Behavioral: MI-Enhanced Text Boosters (2nd Component) · Behavioral: MI-Enhanced Booster Call (3rd Component)

  • Other
    Safety plan + booster text messages (Group B)

    Sequencing of MI-SafeCope intervention components (Phase 1 and Phase 2) resulting in Group B: Participants will receive the in-person MI-enhanced safety plan during hospitalization followed by 4 weeks of daily booster text messages post discharge.

    Behavioral: MI-Enhanced Safety Plan at Hospitalization (1st Component) · Behavioral: MI-Enhanced Text Boosters (2nd Component)

  • Other
    Safety plan + booster call (Group C)

    Sequencing of MI-SafeCope intervention components (Phase 1 and Phase 2) resulting in Group C: Participants will receive the in-person MI-enhanced safety plan during hospitalization followed by a post-discharge booster call.

    Behavioral: MI-Enhanced Safety Plan at Hospitalization (1st Component) · Behavioral: MI-Enhanced Booster Call (3rd Component)

  • Other
    Safety plan (Group D)

    Sequencing of MI-SafeCope intervention components (Phase 1 and Phase 2) resulting in Group D: Participants will receive the in-person MI-enhanced safety plan during hospitalization.

    Behavioral: MI-Enhanced Safety Plan at Hospitalization (1st Component)

Interventions

  • BehavioralMI-Enhanced Safety Plan at Hospitalization (1st Component)

    The MI-enhanced safety plan intervention component is delivered during hospitalization and includes an individual and family meetings. The goal of the individual meeting with the adolescent is to develop an individualized safety plan for use during a suicidal crisis. This "best practices" approach of safety planning is augmented with Motivational Interviewing (MI) as a core strategy to explicitly elicit adolescents' motivation and commitment to behavior change (i.e. use safety plan; adaptive coping), address barriers or ambivalence, and strengthen self-efficacy. The focus of the family meeting, which is similarly guided by MI, is to prepare parents/guardians, with input from the adolescent, for how they may support the adolescent in implementing the individualized safety plan after discharge and on strengthening parents' commitment and self-efficacy.

  • BehavioralMI-Enhanced Text Boosters (2nd Component)

    For participants randomized to receive text boosters, booster text messages will be sent daily for 4 weeks. The messages will be tailored to encourage use of individualized coping strategies identified as part of safety planning at hospitalization and will include additional adaptive coping tools and resources. The text message content and tone will be consistent with principles of MI.

  • BehavioralMI-Enhanced Booster Call (3rd Component)

    The focus of the post-discharge booster phone call with adolescent and with parent, each conducted separately, will be to to further adjust the safety plan to better meet post-discharge needs, to further enhance adolescents' motivation and commitment to use coping strategies, and to further support adolescents' and parents' self-efficacy to manage suicidal crises.

06

What researchers measure

Primary outcomes

  1. Percentage of Eligible Participants Recruited to the Study

    Eligible participants were candidates for participation based on medical record review who were approached for consent/assent. The percentage of eligible participants who consented to the study is presented below.

    Time frame: At time of study enrollment, measured following study consent/assent

  2. Percentage of Randomized Participants Who Complete Intervention Components Will be Used to Assess Feasibility and Acceptability

    Outcome measure is showing percentage of randomized adolescent participants who complete intervention components to assess feasibility and acceptability

    Time frame: Following intervention, measured up to 1 month

  3. Percentage of Participants Who Complete Study Assessments Will be Used to Assess Feasibility and Acceptability

    Percentage of participants who complete study assessments, including daily surveys, one month and three month follow ups are used to assess feasibility and acceptability

    Time frame: Following intervention and follow-up assessment, measured up to 3 months

  4. Satisfaction Ratings Will be Used to Assess Acceptability

    Satisfaction was scored by responses to two questions: How satisfied were you? on a 4 point scale, where 1 means very dissatisfied and 4 means very satisfied and how likely would you be to recommend this program to a friend in similar circumstances, on the same point scale, where 1 means definitely not and 4 means definitely yes

    Time frame: Following intervention and follow-up assessment, measured up to 3 months

07

Results

Posted May 28, 2021

Participant flow

Phase 1: Safety Plan (SP) vs. SP w/Texts
Participant flow — Phase 1: Safety Plan (SP) vs. SP w/Texts
MilestoneSafety Plan + Booster Text Messages + Booster CallSafety Plan + Booster Text MessagesSafety Plan + Booster CallSafety Plan
Started040040
Completed040040
Not completed0000
Phase 2: Added Booster Call or Not
Participant flow — Phase 2: Added Booster Call or Not
MilestoneSafety Plan + Booster Text Messages + Booster CallSafety Plan + Booster Text MessagesSafety Plan + Booster CallSafety Plan
Started18221822
Completed180170
Not completed022122
Withdrew: Withdrawal by subject0010
Withdrew: In this smart trial design, this group was randomized to "no booster call.022022
1 Month Follow up Period
Participant flow — 1 Month Follow up Period
MilestoneSafety Plan + Booster Text Messages + Booster CallSafety Plan + Booster Text MessagesSafety Plan + Booster CallSafety Plan
Started18221722
Adolescent surveys completed16221622
Completed16221621
Not completed2011
3 Month Follow up Period
Participant flow — 3 Month Follow up Period
MilestoneSafety Plan + Booster Text Messages + Booster CallSafety Plan + Booster Text MessagesSafety Plan + Booster CallSafety Plan
Started18221722
Adolescent survey completed16211521
Completed15191418
Not completed3334

Outcome measures

PrimaryPercentage of Eligible Participants Recruited to the Study

Eligible participants were candidates for participation based on medical record review who were approached for consent/assent. The percentage of eligible participants who consented to the study is presented below.

Time frame:
At time of study enrollment, measured following study consent/assent
Reported as:
Number · Percentage of eligible participants
Percentage of Eligible Participants Recruited to the Study
Percentage of eligible participantsAll Eligible Youth
Percentage of Eligible Participants Recruited to the Study87.2
PrimaryPercentage of Randomized Participants Who Complete Intervention Components Will be Used to Assess Feasibility and Acceptability

Outcome measure is showing percentage of randomized adolescent participants who complete intervention components to assess feasibility and acceptability

Time frame:
Following intervention, measured up to 1 month
Reported as:
Number · percent of participants
Percentage of Randomized Participants Who Complete Intervention Components Will be Used to Assess Feasibility and Acceptability
percent of participantsSafety Plan + Booster Text Messages + Booster Call (Group A)Safety Plan + Booster Text Messages (Group B)Safety Plan + Booster Call (Group C)Safety Plan (Group D)
Safety Plan (Phase 1)100100100100
Booster Texts100100——
Booster Call (Phase 2)88.9—88.9—
PrimaryPercentage of Participants Who Complete Study Assessments Will be Used to Assess Feasibility and Acceptability

Percentage of participants who complete study assessments, including daily surveys, one month and three month follow ups are used to assess feasibility and acceptability

Time frame:
Following intervention and follow-up assessment, measured up to 3 months
Reported as:
Number · percent of participants
Percentage of Participants Who Complete Study Assessments Will be Used to Assess Feasibility and Acceptability
percent of participantsSafety Plan + Booster Text Messages + Booster Call (Group A)Safety Plan + Booster Text Messages (Group B)Safety Plan + Booster Call (Group C)Safety Plan (Group D)
Percentage of Participants Who Complete Study Assessments Will be Used to Assess Feasibility and Acceptability10010094.4100
PrimarySatisfaction Ratings Will be Used to Assess Acceptability

Satisfaction was scored by responses to two questions: How satisfied were you? on a 4 point scale, where 1 means very dissatisfied and 4 means very satisfied and how likely would you be to recommend this program to a friend in similar circumstances, on the same point scale, where 1 means definitely not and 4 means definitely yes

Time frame:
Following intervention and follow-up assessment, measured up to 3 months
Reported as:
Mean · units on a scale
Satisfaction Ratings Will be Used to Assess Acceptability
units on a scaleSafety Plan + Booster Text Messages + Booster Call (Group A)Safety Plan + Booster Text Messages (Group B)Safety Plan + Booster Call (Group C)Safety Plan (Group D)
Satisfaction score3.59 ± 0.513.55 ± 0.513.31 ± 0.793.55 ± 0.6
Likelihood of recommending plan to a friend score3.82 ± 0.393.77 ± 0.433.38 ± 0.813.64 ± 0.49

Adverse events

Collected over Data on suicide attempts was collected over a 3 month period.. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Safety Plan + Booster Text Messages + Booster Call (Group A)0/18 (0%)0/15 (0%)—
Safety Plan + Booster Text Messages (Group B)0/22 (0%)2/19 (10.5%)—
Safety Plan + Booster Call (Group C)0/18 (0%)3/14 (21.4%)—
Safety Plan (Group D)0/22 (0%)3/20 (15%)—
Most frequent serious events
Most frequent serious events
EventSafety Plan + Booster Text Messages + Booster Call (Group A)Safety Plan + Booster Text Messages (Group B)Safety Plan + Booster Call (Group C)Safety Plan (Group D)
Suicide AttemptPsychiatric disorders0/152/193/143/20

Baseline characteristics

Phase 1 assigned all 80 participants to safety plan(SP) or SP+text. Phase 2 added booster calls vs. no calls to Phase 1 interventions. Each participant of the 80 is fully included in the two groups shown here. For race, some participants self-described in \>1 category, not as "More than 1 race". Thus the totals of participants' self-descriptions for race in each column exceed the actual 40 people shown in other baseline measures.

Age, Continuous
Age, Continuous(years)Phase 1 - Safety PlanPhase 1 - Safety Plan & Text MessagesTotal
Mean15.08 ± 1.415.25 ± 1.3215.16 ± 1.35
Sex: Female, Male
Sex: Female, Male(Participants)Phase 1 - Safety PlanPhase 1 - Safety Plan & Text MessagesTotal
Female272754
Male131326
Race (NIH/OMB)
Race (NIH/OMB)(Participants)Phase 1 - Safety PlanPhase 1 - Safety Plan & Text MessagesTotal
American Indian or Alaska Native314
Asian224
Native Hawaiian or Other Pacific Islander011
Black or African American325
White323567
More than one race000
Unknown or Not Reported112
Count of participants with at least one suicide attempt during their lifetime
Count of participants with at least one suicide attempt during their lifetime(Participants)Phase 1 - Safety PlanPhase 1 - Safety Plan & Text MessagesTotal
Count of participants211940
Last-month suicide attempt
Last-month suicide attempt(Participants)Phase 1 - Safety PlanPhase 1 - Safety Plan & Text MessagesTotal
Count of participants181230
Multiple attempt history
Multiple attempt history(Participants)Phase 1 - Safety PlanPhase 1 - Safety Plan & Text MessagesTotal
Count of participants141428
Lifetime nonsuicidal self-injury
Lifetime nonsuicidal self-injury(Participants)Phase 1 - Safety PlanPhase 1 - Safety Plan & Text MessagesTotal
Count of participants313162
Suicidal ideation mean
Suicidal ideation mean(units on a scale)Phase 1 - Safety PlanPhase 1 - Safety Plan & Text MessagesTotal
Mean3.90 ± .903.93 ± 0.923.91 ± 0.90

1 further baseline measures are reported on the registry.

08

Study locations

1 site
  • University of Michigan
    Ann Arbor, Michigan 48109, United States
09

References and documents

Publications

  • Czyz EK, King CA, Prouty D, Micol VJ, Walton M, Nahum-Shani I. Adaptive intervention for prevention of adolescent suicidal behavior after hospitalization: a pilot sequential multiple assignment randomized trial. J Child Psychol Psychiatry. 2021 Aug;62(8):1019-1031. doi: 10.1111/jcpp.13383. Epub 2021 Feb 15. PubMed 33590475 ↗

Study documents

  • Protocol and statistical analysis plan · Mar 21, 2021

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 28, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT03838198
Lead sponsor
University of Michigan
Collaborators
National Institute of Mental Health (NIMH)
Responsible party
Ewa Czyz (Assistant Professor, University of Michigan) — Principal investigator
First posted
Feb 12, 2019
Start date
Mar 14, 2019
Primary completion
Apr 7, 2020
Completion
Apr 7, 2020
Results posted
May 28, 2021
Last update
May 28, 2021

Study contacts

Ewa Czyz
principal investigator · University of Michigan

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion